Five Antigen Tests for COVID-19: Virus Viability Matters

This dataset contains results of high-throughput screening antigent testing for COVID-19 patients in a high-prevalence population (sampling was by nasopharyngeal swabs). The performance of five antigen tests (produced by JOYSBIO, Assure Tech, SD Biosensor, VivaChek Biotech and NDFOS) was evaluated compared to RT-PCR only and after correction on the presence of viable virus particles (i.e., infectiousness). The dataset contains, in total, 1141 patients, of which only samples with discrepant results were subjected to viability testing.

本数据集收录了高流行人群中新型冠状病毒肺炎（COVID-19）患者的高通量抗原筛查检测结果，采样方式为鼻咽拭子。本研究以逆转录聚合酶链式反应（RT-PCR）检测结果为参照标准，评估了5款抗原检测试剂（分别由JOYSBIO、Assure Tech、SD Biosensor、VivaChek Biotech及NDFOS公司生产）的检测性能，并针对样本中活病毒颗粒（即具备感染性）的存在情况开展校正分析。本数据集共纳入1141例患者，其中仅对检测结果不一致的样本进行了活病毒活性检测。